Benzinga | Nov 2, 2021 05:54PM EDT

Ekso Bionics Holdings Q3 EPS $(0.17) Beats $(0.25) Estimate, Sales $3.00M Beat $2.58M Estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.25) by 32 percent. This is a 46.88 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $3.00 million which beat the analyst consensus estimate of $2.58 million by 16.28 percent. This is a 3.56 percent increase over sales of $2.90 million the same period last year.